Annual Drug Patent Expirations for XIFAXAN
Xifaxan is a drug marketed by Salix Pharms and is included in one NDA. It is available from three suppliers. There are twenty-nine patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for XIFAXAN.
This drug has one hundred and eigthy-three patent family members in forty countries.
The generic ingredient in XIFAXAN is rifaximin. Three suppliers are listed for this compound. Additional details are available on the rifaximin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
